BXBin Xia

Bin Xia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bin Xia has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The timing of using IVIG for neonatal ABO hemolytic disease

    by Na Ma, Feihong Zhang, Yong Hu, Bin Xia

    ABO hemolytic disease of the newborn (ABO HDN) is the most prevalent cause of hemolytic disease of the newborn, often leading to hyperbilirubinemia. In some cases, ABO HDN can progress to significant hyperbilirubinemia. The role of intravenous immunoglobulin (IVIG) in treating ABO HDN remains controversial. Several key questions regarding significant hyperbilirubinemia remain unanswered: What are the risk factors of ABO HDN with significant hyperbilirubinemia? Can IVIG provide benefits for ABO HDN with significant hyperbilirubinemia? Where do we place IVIG in the treatment sequence paradigm of ABO HDN? How do we best stratify ABO HDN with significant hyperbilirubinemia for IVIG therapy? We conducted a retrospective cohort study include 948 newborns from West China Second University Hospital, divided into two groups according to the use/nonuse of IVIG. The maternal and neonatal baseline clinical data were collected from digital medical record system. The risk factors of the significant hyperbilirubinemia associated with ABO HDN were investigated using univariate and multivariate analysis. The generalized additive mixed model (GAMM) was used to analyze the nonlinear relationship of bilirubin level with different treatment over time. A total of 948 newborns fulfilled the inclusion criteria, with 143 (15.1%) in the IVIG group, and 805 (84.9%) in the non-IVIG group. (1) The multivariate analysis found that gestational age ≥ 37 weeks (OR 4.19; p = 0.019), age at admission range 24–48 h (OR 9.69; p = 0.03) and age at admission >48 h (OR 50.31; p < 0.0001) were affect significant hyperbilirubinemia in neonates. (2) The total serum bilirubin (TSB) descent speed of IVIG group (0.69µmol/L/h, 95%CI, 0.48–0.89µmol/L/h) was higher than non-IVIG group (0.21µmol/L/h, 95%CI, 0.14–0.29µmol/L/h) among the neonates with age at admission ≤ 48 h (p < 0.0001);No adverse effects related to IVIG treatment were recorded in either group. Regular monitoring of TSB levels starting 24 h after birth is an effective strategy to prevent severe hyperbilirubinemia in ABO HDN. For southwest Chinese neonates, IVIG should not be routinely used to treat ABO HDN in those admitted > 48 h after birth.

  • Open Access

    Case Report: Congenital diaphragmatic hernia associated with esophageal atresia and tracheoesophageal fistula

    by Feihong Zhang, Yang Wu, Li Zhang, Bin Xia

    The coexistence of congenital diaphragmatic hernia and esophageal atresia with or without tracheoesophageal fistula is extremely rare; only 36 cases have been reported. We report a case of a preterm male newborn infant with left congenital diaphragmatic hernia, esophageal atresia, and tracheoesophageal fistula and review 27 related cases.


  • Open Access

    Retinopathy of Prematurity Among Very Low-Birth-Weight Infants in China: Incidence and Perinatal Risk Factors

    by Tian Wu, Li Zhang, Yu Tong, Yi Qu, Bin Xia, Dezhi Mu

    Purpose: Retinopathy of prematurity (ROP) is the leading cause of blindness in children worldwide. This study aimed to determine the incidence and perinatal risk factors for ROP in very low-birth-weight (VLBW) Chinese infants. Methods: A retrospective study of the medical records of 504 VLBW infants screened for ROP from 2012 to 2015 was performed in West China Second University Hospital. VLBW infants were examined according to the Royal College of Ophthalmologists ROP guideline and retinopathy was graded following the International Classification of ROP. Perinatal risk factors for ROP were assessed using univariate and multivariate analyses. Results: The overall incidence of ROP in our study was 26.0% (131/504). Stage 1 ROP, stage 2 ROP, and stage ≥3 ROP were detected in 17.5%, 5.4%, and 3.2% of the infants screened, respectively. In the univariate analysis, many perinatal risk factors were found to have a significant association with ROP. In the subsequent multivariate analysis, in vitro fertilization (IVF) (odds ratio [OR] = 1.896; 95% confidence interval [CI] 1.031–3.486), gestational age (GA) < 32 weeks (OR = 2.171; 95% CI 1.085–4.346), apnea (OR = 2.001; 95% CI 1.224–3.272), bronchopulmonary dysplasia (BPD) (OR = 5.098; 95% CI 2.307–11.265), sepsis (OR = 2.212; 95% CI 1.070–4.576), patent ductus arteriosus (PDA) (OR = 1.675; 95% CI 1.011–2.774), and blood transfusion (OR = 1.819; 95% CI 1.046–3.163) were independently associated with the development of ROP (all P < 0.05). Conclusions: In VLBW Chinese infants, IVF, GA < 32 weeks, apnea, BPD, sepsis, PDA, and blood transfusion were independent perinatal risk factors for ROP.


  • Open Access

    Neonatal-onset carbamoyl phosphate synthetase I deficiency

    by Xiaoyan Yang, Jing Shi, Haihong Lei, Bin Xia, Dezhi Mu

    The carbamoyl phosphate synthetase I deficiency (CPS1D) was rare and hard to diagnose due to its atypical symptoms. Brain magnetic resonance imaging (MRI) was typically unavailable in other reports because most patients died before diagnosis was confirmed. Furthermore, it was found a new mutation that had not been described previously. This is a case of neonatal-onset CPS1D with nonspecific clinical manifestations and deteriorating rapidly. Poor feeding, low activity, and tachypnoea were observed, with rapid progression on day 2 after birth. Severe systematic infection was considered first. However, blood culture and cerebrospinal fluid examination were negative. Symptoms were relief temporarily. Then seizure and tachypnoea reappeared as intravenous amino acids were provided. Further examination indicated severe hyperammonemia (serum ammonia level >500mmol/L). Brain MRI showed diffused white matter lesions. Genetic analysis revealed 2 heterozygous mutations in the CPS1 gene: c.2407C>G (p.803, R>G) in exon 20 and C.323G>A (p.108, G>E) in exon 4. The diagnosis of CSP1D was confirmed. Fasting, the withdrawal of amino acids and plans to treat hyperammonemia were immediately implemented. The parents decided to discontinue medical care. Many CPS1D patients died before the diagnoses are confirmed due to its sudden onset, rapid deterioration, atypical symptoms, and low morbidity. Once hyperammonemia is confirmed, blood and urea amino acid analysis in combination with genetic examinations should be performed as early as possible, this approach would help establish diagnoses at an early stage and thus contribute to reducing mortality and improving prognosis.


    • 1 December 2013
      • Vol. 15  (12) , 1089-92

    [Influence of different antibiotic strategies on outcomes of hospitalized neonates].

    by Bin Xia, Jin-Lin Wu, Li Zhang, Ying Xiong, De-Zhi Mu

    To observe the outcomes of hospitalized neonates who were managed with two different antibiotics strategies, namely, the risk factor based antibiotic strategy and the combination antibiotic strategy that is based on risk factors, infection screening and monitoring. A cohort study was performed on a control group of 4 406 cases of neonates hospitalized between January 2010 and May 2011 and an observed group of 4 476 neonates hospitalized between July 2011 and October 2012. The control group adopted the risk factor based antibiotic strategy and the observed group received a combination antibiotic strategy based on risk factors, infection screening and monitoring. The rate of antibiotic use, average length of stay, readmission rate and mortality rate were compared between the two groups. With the change from the risk factor based antibiotic strategy to the combination antibiotic strategy, the total rate of antibiotic use decreased from 79.6% to 50.5% (P<0.01). There were no differences in the average length of stay, readmission rate, and mortality rate between the two groups. The combination antibiotic strategy based on risk factors, infection screening and monitoring can reduce antibiotic use substantially and has no adverse effects on treatment outcomes in hospitalized neonates.

    • 1 February 2009
      • Vol. 11  (2) , 100-3

    [Evaluation of peripherally inserted central catheters in high risk newborns].

    by Bin Xia, Ying Xiong, Yan-Ling Hu, De-Zhi Mu

    To evaluate the feasibility and safety of the peripherally inserted central catheters (PICC) as a venous access for newborns who need a long-term venous transfusion. Sixty-five newborns receiving PICC and 80 newborns receiving peripheral intravenous catheters (PIV) from April 2006 to February 2008 were included in this study. A retrospective cohort study was used to compare the indwelling time of catheters, catheter-related mechanical complications, the incidence of sepsis, and the mortality between the two groups. The indwelling time of catheters in the PICC and the PIV groups was 18.75+/-7.62 days (range:7-62 days) and 1.49+/-0.57 days (range: 30 minutes to 4 days) respectively. The indwelling time of catheters in the PICC group was significantly longer than that in the PIV group (<0.01). The incidence of catheter-related mechanical complications in the PICC group was significantly lower than that in the PIV group (27.7% vs 63.8%; <0.01). There were no significant differences in the incidence of sepsis and the mortality between the two groups. The application of PICC can cause a decrease in the number of venous puncture. PICC is a safe and effective venous access in newborns.


    • 1 April 2008
      • Vol. 10  (2) , 259-60

    [Asymmetric crying facies: report of five cases].

    by Xiao-Ping Hu, Juan Chen, Bin Xia, De-Zhi Mu

    • 1 June 2007
      • Vol. 9  (3) , 257-8

    [Congenital syphilis: clinical analysis of 18 cases].

    by Bin Xia, Ying Xiong, De-Zhi Mu